Gujarat Kidney and Super Speciality
add_icon

Gujarat Kidney and Super Speciality

130.08
+4.14
(3.29%)
Market Cap
1,025.59 Cr
PE Ratio
59.15
Volume
2,01,169.00
Day High - Low
132.20 - 125.20
52W High-Low
148.34 - 98.36
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
1,025.59 Cr
EPS
2.49
PE Ratio
59.15
PB Ratio
3.93
Book Value
32.03
EBITDA
26.94
Dividend Yield
0.00 %
Sector
Hospitals
Return on Equity
35.02
Debt to Equity
0.39
Forecast For
Actual

Company News

View All News
Caret
neutral
Gujarat Kidney and Super Speciality Limited published its Notice of Postal Ballot in newspapers on June 4, 2026, under Regulation 30.
neutral
Promoters of Gujarat Kidney and Super Speciality Limited confirmed no shares were encumbered in FY26. The disclosure was made to BSE and NSE under SEBI regulations.
neutral
Gujarat Kidney And Superspeciality Limited will hold a board meeting on May 28, 2026, to consider Q4 and FY26 audited results.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
8,498.00
#1 1,22,188.20
61.00
#1 25,228.50
14.70
#1 2,032
33.00
66.96
1,012.45
98,525.06
68.08
8,373.45
16.56
1,464
7.27
53.16
990.35
74,767.28
70.14
9,127.84
16.28
1,064
44.26
65.17
814.95
42,224.27
98.81
4,643.22
8.32
384
#1 79.65
73.71
1,893.90
38,703.89
47.21
7,896.04
#1 41.63
788
13.53
51.01
1,235.10
33,198.30
59.61
4,410.27
16.94
584
39.64
57.03
785.10
31,414.91
126.45
3,904.60
27.31
198
-68.80
58.38
439.75
13,931.61
82.99
2,080.08
18.39
168
17.65
36.54
1,365.00
13,862.82
48.34
1,703.08
8.69
262
38.41
60.90
274.60
11,860.82
#1 43.31
1,679.36
17.77
272
46.56
55.42
Growth Rate
Revenue Growth
103.00 %
Net Income Growth
68.84 %
Cash Flow Change
1,024.79 %
ROE
120.81 %
ROCE
177.89 %
EBITDA Margin (Avg.)
-21.38 %

Quarterly Financial Results

Quarterly Financials
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Revenue
9
12
10
15
13
23
31
Expenses
5
7
7
7
8
16
24
EBITDA
5
5
3
9
5
7
7
Operating Profit %
52 %
39 %
27 %
57 %
40 %
30 %
21 %
Depreciation
1
1
1
1
1
1
2
Interest
0
0
0
0
0
1
1
Profit Before Tax
4
4
2
8
4
5
5
Tax
1
1
0
2
1
1
-0
Net Profit
3
3
1
5
3
4
5
EPS in ₹
0.65
0.52
0.25
0.85
0.47
0.52
0.81

Balance Sheet

Balance Sheet
2022
2023
2024
2025
2026
Total Assets
4
4
21
55
298
Fixed Assets
3
0
14
31
38
Current Assets
1
1
7
22
105
Capital Work in Progress
0
0
0
0
0
Investments
0
0
0
0
2
Other Assets
1
4
7
24
0
Total Equity & Liabilities
4
4
21
55
298
Current Liabilities
4
4
4
22
28
Non Current Liabilities
0
0
6
7
15
Total Equity
0
0
11
27
253
Reserve & Surplus
0
0
2
15
237
Share Capital
0
0
0
11
16

Cash Flow

Cash Flow
2023
2024
2025
Net Cash Flow
0
1
2
Investing Activities
0
0
-18
Operating Activities
0
1
14
Financing Activities
0
-1
6

Share Holding

% Holding
Mar 2025
Dec 2025
Mar 2026
Promoter
99.10 %
71.45 %
71.45 %
FIIs
0.00 %
10.47 %
4.88 %
DIIs
0.00 %
1.67 %
0.56 %
Government
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
11.57 %
10.64 %
Others
0.90 %
4.84 %
12.46 %
No of Share Holders
7
7
18,301

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
14 Feb 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Feb 2026 108.65 110.40
28 May 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
28 May 2026 142.95 135.98

Announcements

Notice Of Postal Ballot10 days ago
Announcement under Regulation 30 (LODR)-Newspaper Publication10 days ago
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 30, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 29, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementMay 28, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementMay 28, 2026
Financial Results As On 31.03.2026May 28, 2026
Board Meeting Outcome for Announcement Of Quarterly And Annual Results For The Financial Year Ended On 31.03.2026May 28, 2026
Board Meeting Intimation for Consideration And Approval Of Audited Quarterly And Yearly Financial Results And Other Matters. May 23, 2026
Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2May 15, 2026
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportMay 15, 2026
GKSL Scales Up Renal Care: 100 Units AI-Powered Haemodialysis Machines To Be Inducted Across Network. First 8 Machines To Go Live At Gujarat Multi Speciality Hospital Godhra Gujarat Within 10 Days Following Completion Of All Required InspectionsMay 14, 2026
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 30, 2026
Announcement under Regulation 30 (LODR)-AcquisitionApr 27, 2026
Appointment of Company Secretary and Compliance OfficerApr 27, 2026
Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotApr 25, 2026
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportApr 25, 2026
Intimation About Payment Of Fine Levied Under Regulation 29 Of SEBI (LODR) Regulations 2015Apr 20, 2026
Intimation Of Receipt Of Notice For Non Compliance With Regulation 29(2)/29(3) Of SEBI (LODR) Regulations 2015Apr 16, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 07, 2026
Closure of Trading WindowMar 26, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationMar 26, 2026
Shareholder Meeting / Postal Ballot-Notice of Postal BallotMar 25, 2026
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 For Wholly Own Subsidiary.Mar 23, 2026
Intimation Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015-Update.Mar 21, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementMar 19, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementMar 19, 2026
Board Meeting Outcome for Outcome For Board Meeting Outcome For Board Meeting Hold On 19Th March 2026.Mar 19, 2026
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Intimation For Receipt Of Notice For Non-Compliance With Regulation 33 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 20Mar 18, 2026
Results-Delay in Financial ResultsMar 13, 2026
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance OfficerMar 03, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 17, 2026
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderFeb 15, 2026
Statement Of Deviation And Variation For Quarter Ended 31 Decembre 2025Feb 15, 2026
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportFeb 14, 2026
Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Quarter And Nine Months Ended December 31 2025Feb 14, 2026
Board Meeting Outcome for Outcome Of The Board Meeting Held On February 14 2026 For The Approval Of The Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Quarter And Nine Months Ended December 31 2025 And Other Businesses MFeb 14, 2026
Board Meeting Intimation for Postponement And Rescheduling Of Board MeetingFeb 11, 2026
Board Meeting Intimation for Approval Of The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2025Feb 10, 2026
Board Meeting Outcome for Board Meeting Outcome For Board Meeting Hold On 5Th February 2026.Feb 05, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 10, 2026
Board Meeting Outcome for Outcome Of Board Meeting Hold On 6Th January 2026.Jan 06, 2026
Board Meeting Outcome for Intimation Of Outcome Of Board Meeting Held On 2Nd January 2026Jan 02, 2026
Closure of Trading WindowDec 30, 2025
Listing of Equity Shares of Gujarat Kidney and Super Speciality LtdDec 30, 2025

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Bandhan BSE Healthcare Index Fund Direct-Growth
0.01%
0
0.00%
0.00%

Technical Indicators

RSI(14)
Neutral
48.52
ATR(14)
Volatile
6.08
STOCH(9,6)
Oversold
17.13
STOCH RSI(14)
Oversold
16.19
MACD(12,26)
Bearish
-1.97
ADX(14)
Strong Trend
29.31
UO(9)
Bearish
32.61
ROC(12)
Downtrend And Accelerating
-7.67
WillR(14)
Neutral
-69.96